Whether that recognition translates into permanent coverage will depend on what emerges from the BALANCE Model deliberations, the utilisation data the Bridge generates, and the political appetite for absorbing a multi-billion-dollar annual cost
Pfizer Discontinues Danuglipron Trials Due to High Dropout Rates The company decided to continue forward with its twice-a-day formulation of danuglipron
Medication review : Assess for concurrent medications that may increase stone risk (loop diuretics, topiramate, acetazolamide, triamterene, indinavir, high-dose vitamin C, and vitamin D supplements, particularly when combined with calcium supplementation)
277: R910-916
As you can understand, like everything in medicine, you have to know how much to give, how often to give, and if I do that part, when can I see the results